Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603044 · ClinicalTrials.gov registry record · Phase 4
Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00603044 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 24 participants.
The verdict
NCT00603044, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in the adenoid tissues of children with OSAS. This will result in a local reduction in inflammation and edema explaining the improvement in OSAS.
Interventions
- DRUG fluticasone furoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603044
The ClinicalTrials.gov registry entry for NCT00603044 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluticasone furoate is the first listed.
NCT00603044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603044 about?
NCT00603044 is a clinical study titled "Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome". The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in th...
What is the current status of trial NCT00603044?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2008-01. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00603044?
The interventions under investigation include: fluticasone furoate (DRUG).
Who is sponsoring clinical trial NCT00603044?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.